investors.curis.com
Investor Relations - Curis - Investor RelationsThe Investor Relations website contains information about Curis, Inc. business for stockholders, potential investors, and financial analysts.
http://investors.curis.com/
The Investor Relations website contains information about Curis, Inc. business for stockholders, potential investors, and financial analysts.
http://investors.curis.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
0.4 seconds
16x16
PAGES IN
THIS WEBSITE
15
SSL
EXTERNAL LINKS
74
SITE IP
199.230.20.237
LOAD TIME
0.362 sec
SCORE
6.2
Investor Relations - Curis - Investor Relations | investors.curis.com Reviews
https://investors.curis.com
The Investor Relations website contains information about Curis, Inc. business for stockholders, potential investors, and financial analysts.
investors.curis.com
Stock Information - Curis, Inc.
http://investors.curis.com/stockquote.cfm
4:00 PM ET on Aug 26, 2016. Sign up for email alerts. The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by eSignal, stock charts are provided by NASDAQ OMX, both third party services, and Curis, Inc. does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes.
Events & Presentations - Curis, Inc.
http://investors.curis.com/events.cfm
Details on upcoming events are not yet available. Please click here. To be notified of all upcoming events. Aug 4, 2016. Q2 2016 Curis Inc Earnings Conference Call. Jun 8, 2016. May 9, 2016. Q1 2016 Curis Inc Earnings Conference Call. Mar 15, 2016. 28th Annual Roth Conference. Mar 8, 2016. Cowen and Company 36th Annual Health Care Conference. Feb 29, 2016. Q4 2015 Curis Inc Earnings Conference Call. Feb 24, 2016. 2016 RBC Capital Markets Global Healthcare Conference. Feb 8, 2016. Dec 9, 2015. Dec 6, 2015.
Corporate Governance - Curis, Inc.
http://investors.curis.com/corporate-governance.cfm
Nominating and Corporate Governance Committee Charter. Science and Technology Committee Charter. Code of Business Conduct and Ethics. Add file to Briefcase.
Board of Directors - Curis, Inc.
http://investors.curis.com/directors.cfm
Show all ». James R. McNab, Jr. Chairman of the Board, Curis. Member of the Audit Committee. Daniel R. Passeri. Vice Chairman of the Board, Curis. Ali Fattaey, Ph.D. President and Chief Executive Officer. Martyn D. Greenacre. Former senior executive at GSK; Director, Cephalon and Chairman, BMP Sunstone. Chair of the Audit Committee. Member of the Nominating and Governance Committee. Kenneth I. Kaitin, Ph.D. Chair of the Nominating and Governance Committee. Member of the Compensation Committee.
Management - Curis, Inc.
http://investors.curis.com/management.cfm
Show all ». Ali Fattaey, Ph.D. President and Chief Executive Officer. Dr Fattaey has served as the company’s Director, President and Chief Executive Officer since June 2014. He joined the company in 2013 as President and Chief Operating Officer. President, Chief Executive Officer and Director, ACT Biotech, Inc. Vice President, Research, Chiron Corporation (acquired by Novartis). Chief Scientific Officer, Sagres Discovery (acquired by Chiron). Director, EpiTherapeutics ApS (acquired by Gilead). Senior Med...
TOTAL PAGES IN THIS WEBSITE
15
jimsbusinessinvestingideas.blogspot.com
Jim's Business & Investing Ideas...sugar free: January 2012
http://jimsbusinessinvestingideas.blogspot.com/2012_01_01_archive.html
Jims Business and Investing Ideas.sugar free. Welcome to the blog. Please sign up for updates and be sure to follow me on twitter at hogsnstocks@twitter.com. I will be posting daily so visit often. Im adding some helpful links to tools and products that can help you succeed in business and in play. Remember life is too short so we need to PLAY. Friday, January 27, 2012. The Stock Fizzlers continue. The new excuse they use is the stock had good volume but was having technical issues. HELLOOOOO. Even stock...
StocksDiva: Curis, Inc.~ Nasdaq Bio~ CRIS due diligence
http://stocksdiva.blogspot.com/2012/01/curis-inc-nasdaq-bio-cris-due-diligence.html
Educate yourself in the World of FDA and Healthcare. I teach stock market due diligence. I love Due Diligence and BIO's! Tuesday, January 10, 2012. Curis, Inc. Nasdaq Bio CRIS due diligence. Curis, Inc. Nasdaq Bio CRIS due diligence. CRIS Company Overview and Description. Http:/ www.curis.com. CRIS Corporate Fact Sheet:. Http:/ www.curis.com/Corp Fact Sheet 2011.pdf. CRIS Corporate Overview Presentation:. Http:/ www.curis.com/Corporate Overview.pdf. CRIS Key Company Management. Daniel R. Passeri. Http:/ ...
StocksDiva: January 2012
http://stocksdiva.blogspot.com/2012_01_01_archive.html
Educate yourself in the World of FDA and Healthcare. I teach stock market due diligence. I love Due Diligence and BIO's! Tuesday, January 10, 2012. Curis, Inc. Nasdaq Bio CRIS due diligence. Curis, Inc. Nasdaq Bio CRIS due diligence. CRIS Company Overview and Description. Http:/ www.curis.com. CRIS Corporate Fact Sheet:. Http:/ www.curis.com/Corp Fact Sheet 2011.pdf. CRIS Corporate Overview Presentation:. Http:/ www.curis.com/Corporate Overview.pdf. CRIS Key Company Management. Daniel R. Passeri. Http:/ ...
Curis Inc. - CUDC-907
http://www.curis.com/pipeline/cudc-907
Curis CUDC-907 EHA Presentation 2016. Curis CUDC-907 ASCO Poster 2016. Curis CUDC-907 AACR Poster 2016. Curis CUDC-907 Presentation at ASH 2015. Curis CUDC-907 EHA Poster 2015. Curis CUDC-907 ASCO Poster 2015. Curis CUDC-907 AACR Poster 2014. Curis CUDC-907 Poster at ASH 2013. Curis CUDC-907 Poster at AACR 2012. Curis CUDC-907 Poster at AACR 2011. Curis CUDC-907 Poster at EORTC 2011. CUDC-907 (Oral, Small Molecule Dual HDAC and PI3K Inhibitor). About CUDC-907's Clinical Program. In a retrospective post h...
Curis Inc. - Benefits
http://www.curis.com/careers/benefits
Curis provides an excellent core benefit program for employees. You are immediately eligible for coverage no waiting period unless stated otherwise. Curis provides 10 company-paid holidays plus a minimum of one floating holiday, a minimum of three weeks of vacation, and seven sick days annually. Vacation accrual and the number of floating holidays increase after five years of service. A choice of an HMO or PPO medical plan through Harvard Pilgrim Health Care. Vision care benefits through Harvard Pilgrim.
Curis Inc. - Erivedge®
http://www.curis.com/pipeline/erivedge-abcc
Erivedge MIKIE ASCO Poster 2016. Erivedge STEVIE ASCO Poster 2016. Erivedge ERIVANCE 24 Month Update AAD 2014. Erivedge STEVIE ASCO Poster 2013. Erivedge ERIVANCE 18 MONTH Poster ASCO 2013. Genentech ERIVANCE update at ASCO 2012. Vismodegib) for Advanced BCC. Is approved for use in patients with advanced basal cell carcinoma in the U.S., the 28-member states of the European Union, and several other countries worldwide. It is also under regulatory review for commercialization in a number of ad...In less s...
Curis Inc. - Collaborations Overview
http://www.curis.com/collaborations/collaborations-overview
Curis is focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers with substantial unmet therapeutic/medical need. Is the first FDA approved medicine for the treatment of metastatic or locally advanced basal cell carcinoma, or BCC. Erivedge. Is being development and commercialized by Roche and Genentech under a collaboration agreement between Curis and Genentech. Roche and Genentech are also continuing Erivedge. Under the terms of Cur...
Curis Inc. - Site Map
http://www.curis.com/sitemap-footer
Lori Kunkel, M.D. Senior Manager/Associate Director, Competitive Intelligence and Program Management. Remote Clinical Research Associate. In-House Clinical Research Associate.
TOTAL LINKS TO THIS WEBSITE
74
Investor Relations Home - Investors - CSX
To report an emergency, call 1-800-232-0144 Contact Us. Our Evolution and History. Message from Our Chairman. New to CSX or Rail? Other Services and Partners. Short Line and Regional Railroads. Product Transloading and Distribution. Price Lists, Publications, Tariffs and Fuel Surcharge. Analyst Coverage and Consensus. CSX Direct Stock Purchase Plan. Annual Meeting of Shareholders. Diversity, Inclusion and Engagement. Learn More About CSX. Search Job Openings and Apply. Analyst Coverage and Consensus.
Corporate Profile › Community Trust Bancorp, Inc.
Skip to main content. Savings and Money Market. 24 Hour Convenience Line. Savings and Money Market. 24 Hour Convenience Line. Hours and Locations Map. Wealth and Trust Management. As of August 14, 2015 -. Minimum 20 minute delay. Community Trust Bancorp, Inc. ( CTBI ). Forbes Magazine Recognizes Community Trust Bancorp, Inc. For the Second Consecutive Year as One of America's 50 Most Trustworthy Financial Companies. Community Trust Bancorp, Inc. Increases Its Cash Dividend. Community Trust Bancorp, Inc&#...
Investors | Computer Task Group, Inc.
Skip to main navigation. Skip to main content. Corporate and Social Responsibility. Industry Recognition and Awards. Quality Assurance and Testing. Healthcare and Life Sciences. Backed by nearly 50 years of experience, CTG has a proven track record of delivering high-value, industry-specific solutions that provide real business value to our customers. Mar 20, 2018. CTG Proposes to Declassify Its Board of Directors. Mar 16, 2018. View all News Releases. Feb 20, 2018. View all Events and Presentations.
User Login
Investor Relations, Corporate Profile | CubeSmart, U•Store•It Reinvented
Choose your storage type:. Report of Organizational Actions - IRS form 8937. CUBESMART (NYSE - CUBE). Friday, August 07, 2015. CubeSmart Second Quarter 2015 Earnings Call. Our strategy is to grow our property portfolio by being a consolidator in the highly fragmented self-storage industry. We believe these acquisitions will offer the Company economies of scale by spreading our management expertise and operating efficiency across a larger portfolio. We look to maximize the cash flow from our facil...As of...
Investor Relations - Curis - Investor Relations
Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers. The Company currently has two drug candidates in development:. CUDC-907, an orally available small molecule inhibitor of HDAC and PI3K enzymes being investigated in a Phase 2 clinical trial in patients with MYC-altered diffuse large B-cell lymphoma and in a Phase 1 trial in patients with MYC-altered solid tumors. Mar 8, 2018. Mar 5, 2018. Curis,...
Investor Home | Investors | Cynosure
Your Practice and Cynosure. Q2 2015 Cynosure Inc. Earnings Conference Call. 160;at 9:00 am ET. Q2 2015 Cynosure Inc. Earnings Conference Call. Tuesday, July 28, 2015 . 9:00 am ET . Click here for webcast. 160; 0.62. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. July 28, 2015. Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year. July 14, 2015. Cynosure to Host Second-Quarter 2015 Financial Results Conference Call on July 28.
Investor Relations - Cypress Semiconductor Corporation
Body and Comfort Electronics. 80211n Wi-Fi with MCU. Bluetooth Low Energy (BLE). PSoC 6 32-bit IoT MCUs. Traveo 32-bit ARM Auto MCUs. PSoC 32-bit ARM Cortex MCUs. 16-bit and 8-bit MCUs. Universal Serial Bus (USB). USB Type-C and Power Delivery. LED Lighting Driver ICs. Serial (QSPI) NOR Flash. Create a Support Case. Report a Website Problem. Bluetooth Low Energy (BLE). Universal Serial Bus (USB). Environmental Health and Safety. 10 being Extremely likely, 5 being neutral and 0 being not likely at all.
DanDrit Biotech USA, Inc.—Investor Relations
DanDrit Biotech USA, Inc. Quarterly report [Sections 13 or 15(d)]. Acc-no: 0001213900-15-003597 (34 Act) Size: 3 MB. Current report, item 5.02. Acc-no: 0001615774-15-000993 (34 Act) Size: 14 KB. Current report, item 5.02. Acc-no: 0001615774-15-000864 (34 Act) Size: 18 KB. Annual report [Section 13 and 15(d), not S-K Item 405]. Acc-no: 0001213900-15-002253 (34 Act) Size: 6 MB. Current report, items 1.01, 5.02, and 9.01. Acc-no: 0001213900-15-001869 (34 Act) Size: 85 KB. Current report, items 1.01, 8&#...
Corporate Profile | DCT
Active in the Market. SEC Filings and Financial Documents. Tax Treatment of Dividends. DRIP Dividend Reinvestment Plan. Email / Mobile Notifications. REITWeek: NAREIT’s Investor Forum for 2015. Wednesday June 10, 2015 at 10:15 AM ET. REITWeek: NAREIT’s Investor Forum for 2015. Click here to view the archived webcast. DCT Industrial Second Quarter 2015 Earnings Call. Friday July 31, 2015 at 11:00 AM ET. Click here to download Adobe Acrobat Reader. As of August 7, 2015. Minimum 20 minute delay. College Sta...
Willkommen bei Investors Management in Stuttgart
BGV / Badische Allgemeine. Vita - Armin Sturm. Ihr Weg zu uns. Intelligente Lösungen für Makler und Vertriebsgesellschaften - Wir begleiten Sie vom Angebot bis zur Vertragsverwaltung. Intelligente Lösungen für Makler und Vertriebsgesellschaften. Der Service für Makler ist unsere erste Pflicht. Die Vielzahl der Anbieter im Bereich. Finanzdienstleistungen, geht weit über unsere Vorstellungskraft hinaus. Somit ist es für einen einzelnen Makler nur mit sehr hohem Aufwand möglich,. News aus dem Markt:.
SOCIAL ENGAGEMENT